September 2021 - Patrick Anquetil sat down with ASAP Biopharma ahead of his keynote "Alliance Managers Are Bringing Digital Health Innovation" which is slated for 10:20 a.m. EDT on September 28th. The keynote will be followed by a Q&A session.
Patrick Anquetil, PhD, MBA sat down with ASAP Biopharma ahead of his keynote “Alliance Managers Are Bringing Digital Health Innovation” which is slated for 10:20 a.m. EDT on September 28th. Dr. Anquetil will reveal how Portal’s alliance governance, framework, and execution are inextricably linked to the advancement of this groundbreaking drug-delivery mechanism. After the keynote Dr. Anquetil plans to have a Q&A session and discussion of any aspect of innovation that isn’t covered in his presentation, including but not limited to issues related to regulatory, manufacturing, and commercial phases of the drug development life cycle.
Read the full interview here: ASAP BioPharma Conference Keynote Preview: Alliance Managers Are Bringing Digital Health Innovation
June 30, 2022 - Logan Merrill has taken testosterone injections for 6 years. In this piece, Logan talks about his transition and the process of taking his injections. This blog was written by Logan Merrill for Portal Instruments. All opinions and experiences shared are entirely his own.
January 2025 – Portal Instruments, a leader in innovative drug delivery technology, recently announced the launch of PRIME Nexus, a cutting-edge reusable electronic injector designed to enhance the administration of injectable medications while helping partners meet their sustainability goals.
June 30, 2021 - The National Transgender Discrimination Survey Report on Health and Health Care recorded at least 80% of transgender people have either taken gender-affirming hormone therapy (GAHT) or want to take GAHT at some point.¹
Please fill out the details below and we will get back to you shortly.